Actively Recruiting
Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control
Led by Mayo Clinic · Updated on 2025-10-22
150
Participants Needed
1
Research Sites
36 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to prove that data generated by your real-time personal continuous glucose monitors CGMs brought in the hospital at the time of hospitalization can be monitored and safely used to guide insulin therapy aiming to improve glycemic control and to diminish the hypoglycemia and hyperglycemia episodes without negatively affecting patients' satisfaction, providers and your nurses satisfaction with how glucose is monitored and treated in the hospital.
CONDITIONS
Official Title
Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older at time of consent
- Male or female
- Admitted to a non-ICU medical or surgical ward or enrolled in Advanced Care at Home Program
- Admitted under observation or inpatient status
- Expected hospital stay longer than 48 hours
- Currently using a transcutaneous or implantable real-time CGM and bringing it to the hospital
- Diagnosed with diabetes mellitus or hyperglycemia treated with subcutaneous insulin in hospital
You will not qualify if you...
- Unable to provide informed medical consent
- Admitted to Intensive Care Units (ICU); enrollment possible after transfer out of ICU
- Actively treated for diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)
- Diagnosis of liver cirrhosis
- Diagnosis of end-stage renal disease (ESRD) or acute renal failure on hemodialysis or peritoneal dialysis
- Planned MRI or surgical procedure; enrollment possible after procedure
- Allergy to medical grade adhesive or medical tape
- Pregnant, wanting to become pregnant, or nursing during study
- Using Medtronic or Dexcom sensors and taking acetaminophen over 4g per day or more than 1g every 6 hours
- Using Dexcom sensors and taking hydroxyurea
- Using Libre sensors and taking over 500 mg of ascorbic acid
- Using Eversense sensors and taking tetracycline antibiotics
- Actively enrolled in other CGM studies without permission from prior study investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
Actively Recruiting
Research Team
A
Adrian G Dumitrascu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here